WHO ICTRP trial

High Flow Nasal Oxygenation for General Thoracic Patients during Diagnostic…

ACTRN12615000206527 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12615000206527
Public title High Flow Nasal Oxygenation for General Thoracic Patients during Diagnostic Bronchoscopy. Comparison of conventional methods of respiratory support during bronchoscopy vs. High Flow Nasal Cannula.
Scientific title General thoracic patients undergoing diagnostic bronchoscopy receiving High Flow oxygen therapy for respiratory support vs. conventional low flow oxygen therapy for respiratory support to reduce recovery/hospital time and maintain lung volumes
Primary sponsor Professor John Fraser
Secondary sponsors Amanda Corley
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Respiratory support for general thoracic patients undergoing Bronchoscopy; Respiratory support for general thoracic patients undergoing Bronchoscopy;Respiratory - Other respiratory disorders / diseases;Anaesthesiology - Other…
Interventions Nasal high flow oxygen therapy has been widely investigated in many areas of in-hospital patient care. It can deliver up to 60L/min of humidified air and oxygen. Documented mechanisms of action for high flow include dead space clearance and…
Registration date Mar 3, 2015
Target size 34
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations